Abstract
Viral clearance and inactivation by the bulk protein purification process are critical components of the overall strategy to ensure the safety of therapeutic proteins derived from mammalian cell culture. A mechanistic understanding of the factors that influence viral clearance and inactivation are
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have